Published in Ann Surg on June 01, 1985
Evaluation of the contralateral breast. The role of biopsy at the time of treatment of primary breast cancer. Ann Surg (1992) 1.34
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer (2009) 1.16
Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg (2001) 0.93
Second primary breast cancer. Br Med J (Clin Res Ed) (1988) 0.86
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev (2012) 0.83
Oncoplastic breast reduction: maximizing aesthetics and surgical margins. Int J Surg Oncol (2012) 0.82
The evaluation of contralateral breast lesions in breast cancer patients using reduction mammoplasty. J Breast Cancer (2011) 0.81
Primary bilateral breast cancer. J Natl Med Assoc (1986) 0.78
Changes in mammographically normal contralateral breast in cases of breast carcinoma. Br J Cancer (1989) 0.75
Synchronous breast cancer with different histology. J R Soc Med (1993) 0.75
Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993. Ann Surg (1997) 0.75
Review of general surgery 1985. Postgrad Med J (1986) 0.75
BILATERAL PRIMARY BREAST CANCER; A PROSPECTIVE CLINICOPATHOLOGICAL STUDY. Cancer (1964) 3.80
Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer (1976) 3.37
Long-term followup of breast cancer patients: the 30-year report. Cancer (1974) 2.86
Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg (1984) 2.36
Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer (1978) 2.23
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA (1978) 1.96
Argument for bilateral mastectomy. Surgery (1951) 1.89
Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol (1978) 1.78
Bilaterality of cancer of the breast. Biopsy of the opposite breast. Cancer (1967) 1.39
The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours. Br J Cancer (1981) 1.34
The clinical significance of pre-invasive breast carcinoma. Cancer (1980) 1.29
Pitfalls of local excision in the treatment of carcinoma of the breast. Surg Gynecol Obstet (1973) 1.25
Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies. Am J Clin Pathol (1973) 1.18
Synchronous and metachronous carcinoma of the breast. Surgery (1982) 1.17
Bilateral breast cancer: biopsy of the opposite breast. Cancer (1977) 1.12
Breast cancer mammography patterns. Cancer (1977) 1.11
Bilateral carcinoma of the breast. Am J Surg (1973) 1.06
Bilateral breast cancer in patients with initial stage I and II disease. Cancer (1982) 1.01
Bilateral breast cancer. Surg Clin North Am (1978) 1.01
Experiences with bilateral primary carcinoma of the breast. Surg Gynecol Obstet (1973) 1.00
Bilateral breast cancer at the Johns Hopkins Hospital. A discussion of the dilemma of contralateral breast cancer. Cancer (1971) 0.99
Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer (1981) 0.95
Management of the contralateral breast after mastectomy for unilateral carcinoma. Surg Gynecol Obstet (1973) 0.94
Prognosis of the second breast cancer. The role of previous exposure to the first primary. Cancer (1975) 0.93
Simultaneous bilateral cancer of the brease--evaluation of the use of a contralateral biopsy. Acta Chir Scand (1980) 0.91
The potential for carcinoma existing synchronously on a microscopic level within the second breast. Surg Gynecol Obstet (1975) 0.89
Bilateral breast cancer in northern Alberta: risk factors and survival patterns. Can Med Assoc J (1984) 0.89
Managing the remaining breast. Cancer (1980) 0.86
Experience with opposite breast biopsy in patients with operable breast cancer. Cancer (1976) 0.85
Detection of breast cancer in a specialized cancer detection center. Cancer (1969) 0.85
Bilateral carcinoma of the breast. Br J Surg (1980) 0.84
Factors influencing survival in bilateral breast cancer. J Surg Oncol (1981) 0.82
Bilateral carcinoma of the breast. Aust N Z J Surg (1976) 0.78
A thirty year study of breast cancer in a consecutive series of private patients. Is axillary nodal study a valuable index in prognosis? Am J Surg (1978) 0.78
Synergism between morphogenetic mutants of Myxococcus xanthus. Dev Biol (1978) 10.25
Social gliding is correlated with the presence of pili in Myxococcus xanthus. Proc Natl Acad Sci U S A (1979) 8.66
Cell-to-cell stimulation of movement in nonmotile mutants of Myxococcus. Proc Natl Acad Sci U S A (1977) 7.67
Construction of Tn5 lac, a transposon that fuses lacZ expression to exogenous promoters, and its introduction into Myxococcus xanthus. Proc Natl Acad Sci U S A (1984) 5.82
Myxobacteria: cell interactions, genetics, and development. Annu Rev Microbiol (1979) 5.80
A global analysis of developmentally regulated genes in Myxococcus xanthus. Dev Biol (1986) 5.21
Nutrition of Myxococcus xanthus, a fruiting myxobacterium. J Bacteriol (1978) 4.89
Type IV pili and cell motility. Mol Microbiol (1999) 4.87
Fruiting body morphogenesis in submerged cultures of Myxococcus xanthus. J Bacteriol (1982) 4.29
Introduction of transposon Tn5 into Myxococcus for analysis of developmental and other nonselectable mutants. Proc Natl Acad Sci U S A (1981) 4.19
Induction of coordinated movement of Myxococcus xanthus cells. J Bacteriol (1982) 3.98
Developmental cell interactions in Myxococcus xanthus and the spoC locus. Proc Natl Acad Sci U S A (1983) 3.92
Systematic isolation of transducing phages for Myxococcus xanthus. Virology (1978) 3.76
Expression of many developmentally regulated genes in Myxococcus depends on a sequence of cell interactions. Genes Dev (1987) 3.76
Genetic and functional evidence that Type IV pili are required for social gliding motility in Myxococcus xanthus. Mol Microbiol (1995) 3.58
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Intercellular signaling is required for developmental gene expression in Myxococcus xanthus. Dev Biol (1986) 3.52
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39
Evolution of sensory complexity recorded in a myxobacterial genome. Proc Natl Acad Sci U S A (2006) 3.35
In situ transposon replacement and isolation of a spontaneous tandem genetic duplication. Mol Gen Genet (1983) 3.33
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
The Myxococcus xanthus pilT locus is required for social gliding motility although pili are still produced. Mol Microbiol (1997) 2.91
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
C-factor: a cell-cell signaling protein required for fruiting body morphogenesis of M. xanthus. Cell (1990) 2.73
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Developmental cell interactions of Myxococcus xanthus: analysis of mutants. J Bacteriol (1983) 2.58
Regulation of expression of the pilA gene in Myxococcus xanthus. J Bacteriol (1997) 2.53
Cell interactions in myxobacterial growth and development. Science (1985) 2.35
Murein components rescue developmental sporulation of Myxococcus xanthus. J Bacteriol (1982) 2.31
Identification of heat-stable A-factor from Myxococcus xanthus. J Bacteriol (1992) 2.27
Genes required for developmental signalling in Myxococcus xanthus: three asg loci. J Bacteriol (1989) 2.23
Cell alignment required in differentiation of Myxococcus xanthus. Science (1990) 2.21
Lobular capillary hemangioma: the underlying lesion of pyogenic granuloma. A study of 73 cases from the oral and nasal mucous membranes. Am J Surg Pathol (1980) 2.18
Avoiding the 'costs' of testosterone: ecological bases of hormone-behavior interactions. Brain Behav Evol (2001) 2.09
Maltophilin: a new antifungal compound produced by Stenotrophomonas maltophilia R3089. J Antibiot (Tokyo) (1996) 2.07
devRS, an autoregulated and essential genetic locus for fruiting body development in Myxococcus xanthus. J Bacteriol (1993) 2.06
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer (1994) 2.06
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
DNA packaging steps in bacteriophage lambda head assembly. J Mol Biol (1975) 2.05
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
The guanosine nucleotide (p)ppGpp initiates development and A-factor production in myxococcus xanthus. Genes Dev (1998) 2.00
Gliding motility in Myxococcus xanthus: mgl locus, RNA, and predicted protein products. J Bacteriol (1989) 2.00
Control of cell density and pattern by intercellular signaling in Myxococcus development. Annu Rev Microbiol (1992) 1.99
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Gene transfer to myxobacterium by Escherichia coli phage P1. Science (1975) 1.97
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol (1988) 1.96
Proteins that rescue A-signal-defective mutants of Myxococcus xanthus. J Bacteriol (1992) 1.96
Ectopic production of guanosine penta- and tetraphosphate can initiate early developmental gene expression in Myxococcus xanthus. Genes Dev (1995) 1.94
Intercellular C-signaling and the traveling waves of Myxococcus. Genes Dev (1994) 1.92
Characterizations of highly expressed genes of four fast-growing bacteria. J Bacteriol (2001) 1.92
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
The Myxococcus xanthus pilQ (sglA) gene encodes a secretin homolog required for type IV pilus biogenesis, social motility, and development. J Bacteriol (1999) 1.87
dsg, a gene required for cell-cell interaction early in Myxococcus development. J Bacteriol (1989) 1.86
A-signalling and the cell density requirement for Myxococcus xanthus development. J Bacteriol (1992) 1.85
Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol (1986) 1.82
A link between cell movement and gene expression argues that motility is required for cell-cell signaling during fruiting body development. Genes Dev (1988) 1.82
Histologic classification of sinonasal intestinal-type adenocarcinoma. Am J Surg Pathol (1991) 1.80
The act operon controls the level and time of C-signal production for Myxococcus xanthus development. Mol Microbiol (2001) 1.80
Value-based surgical pathology: a valuable concept. Am J Clin Pathol (1997) 1.79
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Cell behavior in traveling wave patterns of myxobacteria. Proc Natl Acad Sci U S A (2001) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
C-factor has distinct aggregation and sporulation thresholds during Myxococcus development. J Bacteriol (1991) 1.76
Intercellular C-signaling in Myxococcus xanthus involves a branched signal transduction pathway. Genes Dev (1996) 1.75
Guanosine pentaphosphate and guanosine tetraphosphate accumulation and induction of Myxococcus xanthus fruiting body development. J Bacteriol (1980) 1.74
Accumulation of guanosine tetraphosphate and guanosine pentaphosphate in Myxococcus xanthus during starvation and myxospore formation. J Bacteriol (1980) 1.72
Suppressors that permit A-signal-independent developmental gene expression in Myxococcus xanthus. J Bacteriol (1991) 1.71
Control of multicellular development: Dictyostelium and Myxococcus. Annu Rev Genet (1986) 1.65
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Markerless deletions of pil genes in Myxococcus xanthus generated by counterselection with the Bacillus subtilis sacB gene. J Bacteriol (1996) 1.63
Two cell-density domains within the Myxococcus xanthus fruiting body. Proc Natl Acad Sci U S A (1993) 1.63
Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer (1994) 1.58
Function of MglA, a 22-kilodalton protein essential for gliding in Myxococcus xanthus. J Bacteriol (1991) 1.57
Cell motility is required for the transmission of C-factor, an intercellular signal that coordinates fruiting body morphogenesis of Myxococcus xanthus. Genes Dev (1990) 1.56
C factor, a cell-surface-associated intercellular signaling protein, stimulates the cytoplasmic Frz signal transduction system in Myxococcus xanthus. Proc Natl Acad Sci U S A (1996) 1.55
Purification and properties of Myxococcus xanthus C-factor, an intercellular signaling protein. Proc Natl Acad Sci U S A (1990) 1.55
Second opinions in surgical pathology. Am J Clin Pathol (1996) 1.53
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Beta-galactosidase activity in single differentiating bacterial cells. Proc Natl Acad Sci U S A (1993) 1.50
Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy. Am J Clin Pathol (1994) 1.50
Upstream gene of the mgl operon controls the level of MglA protein in Myxococcus xanthus. J Bacteriol (1991) 1.50
Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol (1989) 1.49
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
In vitro assembly of bacteriophage Lambda heads. Proc Natl Acad Sci U S A (1973) 1.48
Pattern formation and traveling waves in myxobacteria: theory and modeling. Proc Natl Acad Sci U S A (2001) 1.45
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol (1992) 1.42
Preoperative staging of rectal carcinoma with MR imaging: surgical and histopathologic correlation. Radiology (1990) 1.42
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
An early A-signal-dependent gene in Myxococcus xanthus has a sigma 54-like promoter. J Bacteriol (1995) 1.39
Omental pedicle flap used to treat a bronchopleural fistula after diaphragma--pericardio-pleuropneumonectomy. Thorac Cardiovasc Surg (1990) 1.39
Guardians of the wax ... and the patient. Mod Pathol (1995) 1.38
Standardization of the surgical pathology report. Mod Pathol (1992) 1.38
Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol (1975) 1.31
Alignment enhances the cell-to-cell transfer of pilus phenotype. Proc Natl Acad Sci U S A (1998) 1.31
The pilH gene encodes an ABC transporter homologue required for type IV pilus biogenesis and social gliding motility in Myxococcus xanthus. Mol Microbiol (1998) 1.30